Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study
- 12 January 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Internationales Archiv für Arbeitsmedizin
- Vol. 80 (7), 643-648
- https://doi.org/10.1007/s00420-006-0165-9
Abstract
Objectives Perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) can be released of perfluorinated compounds by biotic and/or metabolic decomposition. Due to their ubiquitous occurrence, persistence and bioaccumulative properties they can be found in blood of the general population all over the world. In animal studies PFOS and PFOA provoked cancer and showed developmental toxic potential besides other adverse health effects. On the basis of the comparison of maternal and umbilical cord plasma sample pairs we wanted to examine whether infants are exposed to PFOS and PFOA via their mothers’ blood. Methods We determined PFOS and PFOA in 11 plasma samples of mothers and the 11 corresponding cord plasma samples of neonates. An analytical method based on plasma protein precipitation followed by HPLC with MS/MS-detection was employed. As internal standards we used 1,2,3,4-13C4-PFOS and 1,2-13C2-PFOA. Results We found PFOS and PFOA in every plasma sample analysed. In maternal plasma samples PFOS concentrations were consistently higher compared to those of the related cord plasma samples (median: 13.0 μg/l vs. 7.3 μg/l). In the case of PFOA we observed only minor differences between PFOA concentrations within the analysed sample pairs (median: 2.6 μg/l vs. 3.4 μg/l for maternal and cord plasma samples, respectively). Discussion For both substances a crossing of the placental barrier could be shown. For PFOS we observed a decrease from maternal to cord plasma concentrations by a factor of 0.41–0.80. To the contrary, PFOA crosses the placental barrier obviously unhindered. These findings show that neonates are exposed to PFOS and PFOA via their mothers’ blood. Given the current situation that only little is known about the consequences of PFOS and PFOA exposure in the early state of development of humans and the fact that in animal studies both substances showed developmental toxic effects further research regarding human health effects is indispensable.This publication has 37 references indexed in Scilit:
- Effects of Perfluorooctanoic Acid Exposure during Pregnancy in the MouseToxicological Sciences, 2006
- Formation of C7F15COOH (PFOA) and Other Perfluorocarboxylic Acids during the Atmospheric Oxidation of 8:2 Fluorotelomer AlcoholEnvironmental Science & Technology, 2005
- Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in ratsToxicology, 2005
- Metabolic products and pathways of fluorotelomer alcohols in isolated rat hepatocytesChemico-Biological Interactions, 2005
- Perfluorinated organic compounds in human blood serum and seminal plasma: a study of urban and rural tea worker populations in Sri LankaJournal of Environmental Monitoring, 2005
- Fluorotelomer Alcohol Biodegradation Yields Poly- and Perfluorinated AcidsEnvironmental Science & Technology, 2004
- A pilot study on the determination of perfluorooctanesulfonate and other perfluorinated compounds in blood of CanadiansPublished by Royal Society of Chemistry (RSC) ,2004
- Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, WashingtonChemosphere, 2004
- Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors.Environmental Health Perspectives, 2003
- Binding of Perfluorooctanoic Acid to Rat and Human Plasma ProteinsChemical Research in Toxicology, 2003